Siemens Healthineers stock falls 1.08 percent as Deutsche Bank holds

Published on 10/05/2026 at 23:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Deutsche Bank assigns Siemens Healthineers a Hold rating and EUR 39 target on October 5, 2026. Q3 revenue reached EUR 5.764 billion, while the stock fell 1.08 percent.

Isometrische Illustration einer Diagnostik-Prozesskette mit Scanner und Labor — Siemens Healthineers DE000SHL1006 visualisiert isometrische Diagnostik-Wertschöpfungskette von Scanner über Labor bis Arztauswertung, Illustration mit AI erstellt.

Siemens Healthineers stock (ISIN DE000SHL1006) was last at EUR 37.45 on Xetra on October 5, 2026, down 1.08 percent from EUR 37.86. The immediate catalyst was a Deutsche Bank Research assessment before the fiscal fourth-quarter results, with a Hold rating and a EUR 39 price target.

Deutsche Bank sees limited upside

According to finanzen.net on October 5, 2026, Deutsche Bank Research kept Siemens Healthineers at Hold with a EUR 39 target. The target stands 4.1 percent above the Xetra price of EUR 37.45, leaving the bank's published view close to the current quotation.

The same report expects 6 percent organic revenue growth in the fourth quarter, while profitability remains the central question for the upcoming results. Deutsche Bank also points to the company's fiscal 2027 adjusted earnings-per-share outlook as an important test for the market.

Q3 delivered revenue and earnings

Siemens Healthineers reported fiscal Q3 2026 revenue of EUR 5.764 billion, up 1.8 percent year over year, according to VCBeat Health. Quarterly net income reached EUR 669 million, an increase of 21.7 percent from EUR 556 million in the prior-year quarter.

The company also reported adjusted quarterly EBIT of EUR 1.101 billion, up 15.6 percent from EUR 953 million. That earnings growth contrasts with the more restrained revenue advance and explains why margin delivery remains more important than headline sales growth for the next update.

Consensus target sits above EUR 45

According to Simply Wall St on October 5, 2026, the consensus rating was Buy from 19 analysts, with an average 12-month target of EUR 45.52. The stock price lies 17.7 percent below that average target, while the published high and low targets were EUR 57.40 and EUR 36.00.

Siemens Healthineers' own investor-relations calendar lists November 5, 2026, for fiscal Q4 results and the analyst call. The company describes its business as medical technology spanning imaging, diagnostics, cancer care and minimally invasive treatment.

Stock last at EUR 37.45

Siemens Healthineers stock was last at EUR 37.45 on Xetra at 5:35 p.m. CEST on October 5, 2026. The session range was EUR 37.20 to EUR 37.84, volume reached 827,026 shares and market capitalization stood at EUR 41.9 billion.